Moderna (MRNA) announced the appointment of Brad Miller as Chief Information Officer effective January 3. Mr. Miller will serve on Moderna’s Executive Committee and report to Chief Executive Officer, Stephane Bancel. Marcello Damiani, who is currently serving in this role as Chief Digital Officer, will be retiring from the company after seven and a half years."I want to express my gratitude to Marcello for his significant contributions over the past seven and a half years. Marcello joined Moderna before our first clinical trial, and where we are today as a digital-first company is a testament to his leadership and ability to scale digital resources during periods of hypergrowth. At the same time, I want to welcome Brad to our team as Chief Information Officer and member of our Executive Committee," said Moderna Chief Executive Officer Stephane Bancel. "Brad comes to us with deep experience leveraging digital and IT solutions to solve complex business challenges, which will be particularly valuable as our company continues its rapid growth globally." Mr. Miller joins Moderna from Capital One (COF), where he served as Executive Vice President and Chief Information Officer. In this role, Mr. Miller led the company’s Enterprise Products and Platforms organization, responsible for building and operating critical enterprise services and digital experiences across all lines of business. In addition to Capital One, Mr. Miller has also held technology leadership roles at Mastercard, where he served as Executive Vice President, Operations and Technology, and Citibank, where he was Head of Global Digital and Cloud Technology. Prior to his posts in the financial services industry, Mr. Miller spent more than 17 years in various engineering roles between Amazon and Microsoft.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on MRNA:
- Pfizer dismisses Moderna claim it copied COVID-19 shot, CNBC reports
- Moderna call volume above normal and directionally bullish
- MRNA, BIIB, or IQV: Which Biotech Stock Earns the Street’s “Strong Buy” Rating?
- Early notable gainers among liquid option names on November 28th
- Barclays reiterates $210 target on Moderna after PSV deep dive